Shopping Cart
- Remove All
- Your shopping cart is currently empty
KB-5246, displays antibacterial activities.is a tetracyclic quinolone.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $1,670 | 6-8 weeks | |
50 mg | $2,180 | 6-8 weeks | |
100 mg | $2,800 | 6-8 weeks |
Description | KB-5246, displays antibacterial activities.is a tetracyclic quinolone. |
In vitro | KB5246, a tetracyclic quinolone with antibacterial properties, effectively inhibits 90% of Escherichia coli, Klebsiella pneumoniae, and Klebsiella oxytoca isolates at concentrations of 0.10 μg/mL or lower. Notably, concentrations of KB-5246 at or above the minimum inhibitory concentration (MIC) prevent regrowth of these organisms after 24 hours of incubation. Additionally, the MICs for 90% of tested isolates (MIC90s) against key gram-positive microorganisms, including methicillin-resistant Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pneumoniae, and Streptococcus pyogenes, are 0.39 μg/mL, showcasing KB-5246's broad-spectrum antibacterial efficacy. |
In vivo | The 50% effective dose (ED50) of KB-5246 for treating S. pneumoniae 2132 infections is 50.5 mg/kg. Its efficacy against S. aureus Smith, P. aeruginosa GN11189, and Serratia marcescens GN7577 is on par with ofloxacin and surpasses that of norfloxacin. |
Molecular Weight | 425.86 |
Formula | C18H17ClFN3O4S |
Cas No. | 119474-55-4 |
Relative Density. | no data available |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.